Alternatively, ERK can stimulate tumor angiogenesis, and inhibition of ERK1/2 signaling in the tumor vasculature results in vessel reduction, defective vascular morphogenesis, and reduced tumor growth [38]. The gene discussed is MAPK3; the disease is neoplasm.